3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Dermatologic
1
Conditions
Colorectal Neoplasms
8
Stomach Neoplasms
3
Rectal Neoplasms
3
Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Hepatocellular
3
Prostatic Neoplasms
2
Pancreatic cancer, adult
2
Lung Neoplasms
2
Recurrence
1
Pancreatic carcinoma, familial
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Metabolic Syndrome
1
Liver Cirrhosis
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Glioblastoma
1
Fibrosis
1
Fatigue
1
Esophageal Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Barrett Esophagus
1
Adenocarcinoma Of Esophagus
1
Interventions
Blood Specimen Collection
4
Reverse Transcriptase Polymerase Chain Reaction
3
Flow Cytometry
3
Surgical Procedures, Operative
2
Propofol
2
Pirinitramide
2
Morphine
2
Laparoscopy
2
Folfox protocol
2
Capecitabine
2
Bevacizumab
2
Aspirin
2
lanreotide
1
Trastuzumab
1
Taxes
1
Standard of Care
1
Sorafenib
1
Sevoflurane
1
Radiotherapy
1
Radiofrequency Ablation
1
Oxaliplatin
1
Octreotide
1
Neoadjuvant Therapy
1
Magnetic Resonance Imaging
1
Leucovorin
1
Injections, Epidural
1
Hematologic Tests
1
Gemcitabine
1
Everolimus
1
Ethiodized Oil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplastic Cells, Circulating
×
Hematologic Tests
×
Gastrointestinal
×
Clear all
NCT02610764
2017-04-13
ESO-CTC
University Hospital Freiburg
Phase NA
Completed
19 enrolled